Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_012031899d142ce7d718005248c98c2c |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-08 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-08 |
filingDate |
2012-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80e5bb13b306b9f446d538a2a28e3b17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aab1a8ae41bb4eebb3b372cf644626ce http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f91ac6d5ff163fb9567a8d7e2c6ec0bf |
publicationDate |
2014-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2014323721-A1 |
titleOfInvention |
Heterocyclic compounds and uses thereof |
abstract |
Heterocyclic entities that modulate PI3 kinase activity, pharmaceutical compositions containing the heterocyclic entities, and methods of using these chemical entities for treating diseases and conditions associated with PI3 kinase activity are described herein. |
priorityDate |
2011-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |